Cohance Lifesciences Limited — Credit Ratings, 27-08-2025: Credit Rating

CRISIL has upgraded Cohance Lifesciences' long-term bank facilities (₹72.5 Cr) to CRISIL AA-/Positive from 'Crisil A+'. Its short-term rating is reaffirmed at CRISIL A1+. This upgrade reflects the company's significantly strengthened business and financial profile post-merger and recent strategic acquisitions, boosting market position and scale in the CDMO space.